$VRTX Recent News Google, Amazon earnings on t
Post# of 94122
Posted On: 02/03/2015 10:51:19 AM
$VRTX Recent News
Google, Amazon earnings on tap after hours 3:40 p.m. Jan. 29, 2015 - Sue Chang
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex Should Expect Approvals For Its Cystic Fibrosis Medications 9:16 p.m. Feb. 2, 2015 - Seeking Alpha
Obama Announces Genetic-Mapping Plan 7:48 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Vertex Pharmaceuticals (VRTX) Downgraded From Hold to Sell 4:40 p.m. Jan. 30, 2015 - TheStreet.com
Is the 'January Effect' Signaling a Down Year for the Stock Market? 3:14 p.m. Jan. 30, 2015 - TheStreet.com
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks? 10:07 a.m. Jan. 30, 2015 - Seeking Alpha
Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape 8:52 a.m. Jan. 30, 2015 - Zacks.com
Vertex Pharma Verging on Full Valuation 8:19 a.m. Jan. 30, 2015 - Barrons.com
Baird Releases Comments After Vertex Earnings Call 2:08 p.m. Jan. 29, 2015 - benzinga.com
Alexion Beats Q4 Estimates, Appoints New CEO 12:28 p.m. Jan. 29, 2015 - Investors Business Daily
Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease 11:44 a.m. Jan. 29, 2015 - TheStreet.com
Maxim Downgrades Vertex Pharmaceuticals After Earnings 11:00 a.m. Jan. 29, 2015 - benzinga.com
Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog 10:10 a.m. Jan. 29, 2015 - Zacks.com
Vertex Phamraceuticals (VRTX) Earnings Report: Q4 2014 Conference Call Transcript 9:03 a.m. Jan. 29, 2015 - TheStreet.com
Continued Expansion Into The Cystic Fibrosis Treatment Market Bodes Well For Vertex 7:52 a.m. Jan. 29, 2015 - Seeking Alpha
Vertex Pharmaceuticals' (VRTX) CEO Jeffrey Leiden on Q4 2014 Results - Earnings Call Transcript 11:36 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2014 Results - Earnings Call Webcast 4:55 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Beats Q4 Revenue Expectations 4:39 p.m. Jan. 28, 2015 - benzinga.com
Today's Post-Market Laggard Is Vertex Pharmaceuticals (VRTX) 4:30 p.m. Jan. 28, 2015 - TheStreet.com
Notable earnings after Wednesday's close 5:35 p.m. Jan. 27, 2015 - Seeking Alpha
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog 11:20 a.m. Jan. 27, 2015 - Zacks.com
Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma 8:55 a.m. Jan. 7, 2015 - PR Newswire - PRF
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results 4:02 p.m. Jan. 6, 2015 - BusinessWire - BZX
On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada 9:20 a.m. Dec. 30, 2014 - PR Newswire - PRF
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:11 p.m. Dec. 29, 2014 - BusinessWire - BZX
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer 9:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
MassMutual Announces the Election of Three Members to its Board of Directors 12:00 p.m. Dec. 10, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Google, Amazon earnings on tap after hours 3:40 p.m. Jan. 29, 2015 - Sue Chang
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex Should Expect Approvals For Its Cystic Fibrosis Medications 9:16 p.m. Feb. 2, 2015 - Seeking Alpha
Obama Announces Genetic-Mapping Plan 7:48 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Vertex Pharmaceuticals (VRTX) Downgraded From Hold to Sell 4:40 p.m. Jan. 30, 2015 - TheStreet.com
Is the 'January Effect' Signaling a Down Year for the Stock Market? 3:14 p.m. Jan. 30, 2015 - TheStreet.com
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks? 10:07 a.m. Jan. 30, 2015 - Seeking Alpha
Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape 8:52 a.m. Jan. 30, 2015 - Zacks.com
Vertex Pharma Verging on Full Valuation 8:19 a.m. Jan. 30, 2015 - Barrons.com
Baird Releases Comments After Vertex Earnings Call 2:08 p.m. Jan. 29, 2015 - benzinga.com
Alexion Beats Q4 Estimates, Appoints New CEO 12:28 p.m. Jan. 29, 2015 - Investors Business Daily
Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease 11:44 a.m. Jan. 29, 2015 - TheStreet.com
Maxim Downgrades Vertex Pharmaceuticals After Earnings 11:00 a.m. Jan. 29, 2015 - benzinga.com
Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog 10:10 a.m. Jan. 29, 2015 - Zacks.com
Vertex Phamraceuticals (VRTX) Earnings Report: Q4 2014 Conference Call Transcript 9:03 a.m. Jan. 29, 2015 - TheStreet.com
Continued Expansion Into The Cystic Fibrosis Treatment Market Bodes Well For Vertex 7:52 a.m. Jan. 29, 2015 - Seeking Alpha
Vertex Pharmaceuticals' (VRTX) CEO Jeffrey Leiden on Q4 2014 Results - Earnings Call Transcript 11:36 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2014 Results - Earnings Call Webcast 4:55 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Beats Q4 Revenue Expectations 4:39 p.m. Jan. 28, 2015 - benzinga.com
Today's Post-Market Laggard Is Vertex Pharmaceuticals (VRTX) 4:30 p.m. Jan. 28, 2015 - TheStreet.com
Notable earnings after Wednesday's close 5:35 p.m. Jan. 27, 2015 - Seeking Alpha
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog 11:20 a.m. Jan. 27, 2015 - Zacks.com
Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma 8:55 a.m. Jan. 7, 2015 - PR Newswire - PRF
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results 4:02 p.m. Jan. 6, 2015 - BusinessWire - BZX
On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada 9:20 a.m. Dec. 30, 2014 - PR Newswire - PRF
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:11 p.m. Dec. 29, 2014 - BusinessWire - BZX
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer 9:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
MassMutual Announces the Election of Three Members to its Board of Directors 12:00 p.m. Dec. 10, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
(0)
(0)
